Skip to main content

Table 1 Nine subgroups ordered by hazard ratio

From: Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Group

Sample size (training cohort)

Hazard ratio

G1-IIIB

32

1.00

G1-IIIA

21

1.71

G2-IIIA

37

2.17

G1-IIIC

12

2.41

G2-IIIB

58

2.46

G3-IIIA

7

3.60

G2-IIIC

24

3.67

G3-IIIC

12

5.17

G3-IIIB

24

6.35